Literature DB >> 16046057

Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.

Michel F P van der Jagt1, Fred C G J Sweep, Erwin T Waas, Thijs Hendriks, Theo J M Ruers, Audrey H H Merry, Theo Wobbes, Paul N Span.   

Abstract

mRNA, and latent and active levels MMP-2 and -9 were higher in tumor tissue compared to normal tissue from 63 patients with colorectal cancer, whereas RECK and EMMPRIN levels were lower. Correlations between mRNA, latent, and active MMP were particular high for MMP-2 in tumor tissue (R(s)=0.6-0.8, P<0.001). For active MMP-2, but not for MMP-9, a significant negative partial correlation (R(p)=-0.440, P<0.001) for RECK was found in tumor tissue, which was confirmed by linear regression analysis. In exploratory survival analyses we found that in patients with localized disease the RECK level in normal or tumor tissue had a significant (P=0.017) association with overall survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16046057     DOI: 10.1016/j.canlet.2005.06.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  22 in total

1.  Low expression of RECK indicates a shorter survival for patients with invasive breast cancer.

Authors:  Yue Zhang; Shaoqiang Cheng; Guoqiang Zhang; Wenjie Ma; Yang Liu; Rui Zhao; Qingyuan Zhang; Da Pang
Journal:  Cancer Sci       Date:  2012-04-19       Impact factor: 6.716

2.  The metalloproteinase inhibitor Reck is essential for zebrafish DRG development.

Authors:  Andrew Prendergast; Tor H Linbo; Tanya Swarts; Josette M Ungos; Hillary F McGraw; Shlomo Krispin; Brant M Weinstein; David W Raible
Journal:  Development       Date:  2012-02-01       Impact factor: 6.868

3.  Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.

Authors:  Xuan Zhang; Caitlin Healy; Warren B Nothnick
Journal:  Endocrine       Date:  2012-08       Impact factor: 3.633

4.  Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases.

Authors:  N Namwat; J Puetkasichonpasutha; W Loilome; P Yongvanit; A Techasen; A Puapairoj; B Sripa; W Tassaneeyakul; N Khuntikeo; S Wongkham
Journal:  J Gastroenterol       Date:  2010-11-13       Impact factor: 7.527

5.  Differential expression of degradome components in cutaneous squamous cell carcinomas.

Authors:  Nijaguna B Prasad; Anne C Fischer; Alice Y Chuang; Jerry M Wright; Ting Yang; Hua-Ling Tsai; William H Westra; Nanette J Liegeois; Allan D Hess; Anthony P Tufaro
Journal:  Mod Pathol       Date:  2013-12-20       Impact factor: 7.842

6.  Interleukin-8 is associated with adhesion, migration and invasion in human gastric cancer SCG-7901 cells.

Authors:  Dawei Ju; Dazhi Sun; Lijuan Xiu; Xianze Meng; Cian Zhang; Pinkang Wei
Journal:  Med Oncol       Date:  2010-12-30       Impact factor: 3.064

7.  Valproic acid affected the survival and invasiveness of human glioma cells through diverse mechanisms.

Authors:  Yun Chen; Ya-Hui Tsai; Sheng-Hong Tseng
Journal:  J Neurooncol       Date:  2012-04-15       Impact factor: 4.130

8.  Up-regulated EMMPRIN/CD147 protein expression might play a role in colorectal carcinogenesis and its subsequent progression without an alteration of its glycosylation and mRNA level.

Authors:  Hua-chuan Zheng; Wei Wang; Xiao-yan Xu; Pu Xia; Miao Yu; Toshiro Sugiyama; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-01       Impact factor: 4.553

Review 9.  Metastasis-suppressor genes in clinical practice: lost in translation?

Authors:  Alexander N Shoushtari; Russell Z Szmulewitz; Carrie W Rinker-Schaeffer
Journal:  Nat Rev Clin Oncol       Date:  2011-04-26       Impact factor: 66.675

Review 10.  A review of clinical and molecular prognostic factors in osteosarcoma.

Authors:  Jonathan C M Clark; Crispin R Dass; Peter F M Choong
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-27       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.